DK0972782T3 - Monoklonalt antistof, der genkender oligosaccharidet N-glycolyleret galactose-glucose-sialinsyre i maligne tumorer, og præparater, der indeholder det - Google Patents
Monoklonalt antistof, der genkender oligosaccharidet N-glycolyleret galactose-glucose-sialinsyre i maligne tumorer, og præparater, der indeholder detInfo
- Publication number
- DK0972782T3 DK0972782T3 DK99903581T DK99903581T DK0972782T3 DK 0972782 T3 DK0972782 T3 DK 0972782T3 DK 99903581 T DK99903581 T DK 99903581T DK 99903581 T DK99903581 T DK 99903581T DK 0972782 T3 DK0972782 T3 DK 0972782T3
- Authority
- DK
- Denmark
- Prior art keywords
- glycolylated
- oligosaccharide
- galactose
- glucose
- monoclonal antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1998022A CU22731A1 (es) | 1998-02-05 | 1998-02-05 | Anticuerpo monoclonal que reconoce el oligosacárido ácido siálico n´glicolilado-galactosa-glucosa (ngcneu-gal-glu) en tumores malignos y composiciones farmacéuticas que los contienen |
| PCT/CU1999/000001 WO1999040119A1 (es) | 1998-02-05 | 1999-02-05 | Anticuerpo monoclonal que reconoce el oligosacarido acido sialico n-glicolilado-galactosa-glucosa en tumores malignos y composicion que lo contiene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0972782T3 true DK0972782T3 (da) | 2004-02-02 |
Family
ID=5459215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99903581T DK0972782T3 (da) | 1998-02-05 | 1999-02-05 | Monoklonalt antistof, der genkender oligosaccharidet N-glycolyleret galactose-glucose-sialinsyre i maligne tumorer, og præparater, der indeholder det |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6429295B1 (ja) |
| EP (1) | EP0972782B1 (ja) |
| JP (1) | JP4125383B2 (ja) |
| CN (1) | CN1149224C (ja) |
| AR (1) | AR013021A1 (ja) |
| AT (1) | ATE250085T1 (ja) |
| AU (1) | AU764632B2 (ja) |
| BR (1) | BR9904773A (ja) |
| CA (1) | CA2286288C (ja) |
| CO (1) | CO4810341A1 (ja) |
| CU (1) | CU22731A1 (ja) |
| DE (1) | DE69911322T2 (ja) |
| DK (1) | DK0972782T3 (ja) |
| ES (1) | ES2209391T3 (ja) |
| MX (1) | MXPA99009082A (ja) |
| PT (1) | PT972782E (ja) |
| WO (1) | WO1999040119A1 (ja) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004531469A (ja) * | 2000-12-08 | 2004-10-14 | チルドレンズ メモリアル ホスピタル | 皮膚疾病の治療に使用するガングリオシドを含む組成物 |
| CU23007A1 (es) * | 2001-04-06 | 2004-12-17 | Ct De Inmunologia Molecular Ct De Inmunologia Mole | Combinaciones inmunoterapéuticas para el tratamiencombinaciones inmunoterapéuticas para el tratamiento de tumores que sobre-expresan gangliósidos to de tumores que sobre-expresan gangliósidos |
| US20040115204A1 (en) * | 2002-12-11 | 2004-06-17 | Fanger Gary R. | Antibodies to treat cancer |
| CA2510250A1 (en) * | 2002-12-20 | 2004-08-12 | Momenta Pharmaceuticals, Inc. | Glycan markers for diagnosing and monitoring disease |
| CU23403A1 (es) * | 2003-04-23 | 2009-08-04 | Centro Inmunologia Molecular | Anticuerpos recombinantes y fragmentos que reconocen el gangliósido n-glicolil gm3 y su uso para diagnóstico y tratamiento de tumores |
| CU23297A1 (es) * | 2004-11-16 | 2008-07-24 | Ct De Inmunologa A Molecular | Formulaciones inmunoterapã0/00uticas para la inducciã"n de autoanticuerpos bloqueadores de la uniã"n de interleucina-2 a su receptor. su uso en el tratamiento del cã ncer |
| CN101835319B (zh) | 2009-03-13 | 2014-05-07 | 奥斯兰姆有限公司 | 用于电子镇流器的外壳 |
| CA3188287A1 (en) | 2010-03-26 | 2011-09-29 | Memorial Sloan-Kettering Cancer Center | Antibodies to muc16 and methods of use thereof |
| WO2012075173A2 (en) | 2010-12-01 | 2012-06-07 | Board Of Regents The University Of Texas System | Compositions and method for deimmunization of proteins |
| WO2012106368A2 (en) | 2011-01-31 | 2012-08-09 | The Regents Of The University Of California | Methods for inhibiting prostate cancer |
| CU24070B1 (es) | 2011-12-27 | 2015-01-29 | Ct De Inmunología Molecular | Composiciones farmacéuticas para el tratamiento de tumores que expresan regf y gangliósidos n-glicolilados gm3 (neugcgm3) |
| CU24120B1 (es) | 2012-03-01 | 2015-08-27 | Ct De Inmunología Molecular | Anticuerpos recombinantes con especificidad dual por los gangliósidos n-acetil gm3 y n-glicolil gm3 |
| CN104651314B (zh) | 2015-02-14 | 2018-06-19 | 百泰生物药业有限公司 | 获得高产稳定表达细胞克隆的方法及由此获得的抗体分子 |
| WO2016149485A1 (en) | 2015-03-17 | 2016-09-22 | The Regents Of The University Of California | Novel chemoimmunotherapy for epithelial cancer |
| AU2016233309B2 (en) | 2015-03-17 | 2021-11-18 | Memorial Sloan Kettering Cancer Center | Anti-MUC16 antibodies and uses thereof |
| CN109721632B (zh) * | 2017-10-27 | 2023-10-31 | 齐鲁制药有限公司 | 一种高纯度神经节苷脂gm1及其制备方法 |
| CU20210104A7 (es) | 2021-12-21 | 2023-07-12 | Ct Inmunologia Molecular | Proteínas de fusión compuestas por un anticuerpo y una muteína agonista de interleucina 2 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4965198A (en) * | 1985-12-24 | 1990-10-23 | Konica Corporation | Monoclonal antibody and method of manufacturing hybridoma producing the same |
| EP0491057B1 (en) * | 1990-07-10 | 1998-12-30 | Nkk Corporation | Hybridoma which produces avian specific immunoglobulin g |
| DE69428763T2 (de) | 1993-12-09 | 2002-08-01 | Ct De Inmunologia Molecular Ci | Monoklonale Antikörper gegen Ganglioside und deren Verwendung in der spezifischen, aktiven Immuntherapie gegen bösartige Tumoren |
-
1998
- 1998-02-05 CU CU1998022A patent/CU22731A1/es unknown
-
1999
- 1999-02-05 JP JP53982099A patent/JP4125383B2/ja not_active Expired - Lifetime
- 1999-02-05 ES ES99903581T patent/ES2209391T3/es not_active Expired - Lifetime
- 1999-02-05 DE DE69911322T patent/DE69911322T2/de not_active Expired - Lifetime
- 1999-02-05 AT AT99903581T patent/ATE250085T1/de active
- 1999-02-05 AU AU24078/99A patent/AU764632B2/en not_active Expired
- 1999-02-05 CN CNB998002615A patent/CN1149224C/zh not_active Expired - Lifetime
- 1999-02-05 WO PCT/CU1999/000001 patent/WO1999040119A1/es active IP Right Grant
- 1999-02-05 BR BR9904773A patent/BR9904773A/pt not_active IP Right Cessation
- 1999-02-05 CA CA2286288A patent/CA2286288C/en not_active Expired - Lifetime
- 1999-02-05 CO CO99006716A patent/CO4810341A1/es unknown
- 1999-02-05 EP EP99903581A patent/EP0972782B1/en not_active Expired - Lifetime
- 1999-02-05 PT PT99903581T patent/PT972782E/pt unknown
- 1999-02-05 US US09/402,521 patent/US6429295B1/en not_active Expired - Lifetime
- 1999-02-05 DK DK99903581T patent/DK0972782T3/da active
- 1999-02-05 AR ARP990100494A patent/AR013021A1/es active IP Right Grant
- 1999-02-05 MX MXPA99009082A patent/MXPA99009082A/es not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4125383B2 (ja) | 2008-07-30 |
| AR013021A1 (es) | 2000-11-22 |
| DE69911322D1 (de) | 2003-10-23 |
| WO1999040119A1 (es) | 1999-08-12 |
| BR9904773A (pt) | 2000-03-21 |
| AU2407899A (en) | 1999-08-23 |
| MXPA99009082A (es) | 2002-04-24 |
| CA2286288C (en) | 2010-09-28 |
| JP2001509684A (ja) | 2001-07-24 |
| EP0972782B1 (en) | 2003-09-17 |
| CU22731A1 (es) | 2002-02-28 |
| CA2286288A1 (en) | 1999-08-12 |
| EP0972782A1 (en) | 2000-01-19 |
| CN1256696A (zh) | 2000-06-14 |
| WO1999040119A9 (es) | 2000-07-06 |
| ATE250085T1 (de) | 2003-10-15 |
| DE69911322T2 (de) | 2004-07-01 |
| US6429295B1 (en) | 2002-08-06 |
| CN1149224C (zh) | 2004-05-12 |
| ES2209391T3 (es) | 2004-06-16 |
| CO4810341A1 (es) | 1999-06-30 |
| PT972782E (pt) | 2004-02-27 |
| AU764632B2 (en) | 2003-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0972782T3 (da) | Monoklonalt antistof, der genkender oligosaccharidet N-glycolyleret galactose-glucose-sialinsyre i maligne tumorer, og præparater, der indeholder det | |
| NO20004657D0 (no) | Kredittkort-system og -fremgangsmÕte | |
| NO20021105D0 (no) | Transaksjonskort | |
| IS5696A (is) | Mótefni gegn CD23, afleiður þeirra og meðferðarnotkun þeirra | |
| DK0965578T3 (da) | Hidtil ukendt triglycerik og præparat, som omfatter dette | |
| NO20011216D0 (no) | Azetidinderivater, fremstilling og medisiner inneholdende disse | |
| NO20011648D0 (no) | Betalingsanordning | |
| NO20013777D0 (no) | Fremgangsmåte for gjennomföring av ikke kontant betaling og system for gjennomföring av fremgangsmåten | |
| NO922155D0 (no) | Peptid og antistoffer som inhiberer integrin-ligandbinding | |
| ATE187325T1 (de) | Verbessertes anti-schuppen-shampoo | |
| DK0988861T3 (da) | Stabiliserede proteinpræparater | |
| FI982117A (fi) | Ennaltamaksetut palvelut liikennöintijärjestelmässä | |
| EP1246686A4 (en) | RAPID IDENTIFICATION OF PROTEINS USING ANTIBODY MIXTURES | |
| NO20003662D0 (no) | Syntetiske polysakkarider, fremgangsmÕte for fremstilling derav og farmasøytiske preparater inneholdende slike | |
| NO960925D0 (no) | Diagnostiske, prognostiske og terapeutiske metoder for faste, ikke-lymfoide tumorer og deres metastaser | |
| WO1997029199A3 (en) | Prostate specific antigen peptides and uses thereof | |
| ATE246494T1 (de) | Brausezubereitungen | |
| DE3584280D1 (de) | Monoklonaler antikoerper gegen menschlichen krebs. | |
| DE29810101U1 (de) | Visitenkarte | |
| EP1016717A4 (en) | NEW PROTEIN EXPRESSES IN LIVER CANCER, GENE-ENCODING IT, ANTIBODIES AGAINST IT AND A METHOD FOR DETECTING THE EXPRESSION OF THIS PROTEIN | |
| DK1192163T3 (da) | Dithiepino[6,5-b]pyriner, beslægtede præparater og fremgangsmåder | |
| DE29813155U1 (de) | Schieberkarte | |
| NO20000079D0 (no) | Ancrod spesifikke monoklonale antistoff, antistoff- fragmenter, blandinger, derivater og anvendelse derav | |
| ES1032815Y (es) | Disposicion perfeccionda de cierre en carros de supermercado o similares. | |
| TR199902750A3 (tr) | Anti-p53 monoklonal antikorlar ve kullanimlari. |